ReviewHealth and quality of life outcomes2025
Patient reported outcomes in the FDA approved drugs for systemic rheumatic diseases (2013-2024).
Yan Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ReviewHealth and quality of life outcomes2025
Yan Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.